Institution
Banner Alzheimer’s Institute
Also known as: BAI
- 17running trials
- 15closed trials
- 1,730publications (OpenAlex)
Running trials
Enrolling by invitation
Recruiting
Recruiting
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Active, not recruiting
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Recruiting
Recruiting
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Recruiting
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Enrolling by invitation
Active, not recruiting
A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease
Enrolling by invitation
Active, not recruiting
Enrolling by invitation
APOE in the Predisposition to, Protection From, and Prevention of Alzheimer's Disease
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Enrolling by invitation
Recruiting
Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease11 recruiting
- Mild cognitive impairment3 recruiting
- Frontotemporal dementia1 recruiting
- Schizophrenia1 recruiting
Closed trials
Completed
Evaluation of a Finger Prick Collection Method for Measuring Alzheimer's Disease Blood Biomarkers
Completed
Draw-10: A Weekly Blood Draw Study to Understand the Biological Variability of Plasma pTau-217
Completed
A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease
Completed
Terminated
Terminated
Open-label Extension for Phase 3 Clinical Trials of Simufilam
Terminated
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease
Terminated
Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
Completed
Completed
Terminated
Completed
Completed
Registry name variants (1)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Banner Alzheimer's Institute
Phoenix, Arizona 85006
33 trials
Conditions
Diseases this institution publishes on or runs trials for.
- Alzheimer disease163 works · 33 trials
- Mild cognitive impairment32 works · 7 trials
Institution data: ROR 023jwkg52 (CC0-1.0)Updated 15 Nov 2026